T2018

Apilimod (STA 5326) inhibits the production of IL-12 and IL-23 and reduces dendritic cell infiltration in psoriasis.

Flucopride (Compound 4a) acts as an acetylcholinesterase inhibitor (AChE) with an IC50 value of 24 nM and serves as a partial agonist for the human 5-HT4 receptor (5-HT4R) with a Ki of 9.6 nM for (h)5-HT4R. It promotes non-amyloidogenic processing of APP in COS-7 cells transiently expressing (h)5-HT4R with an EC50 of 23.0 nM. Flucopride is also likely to exhibit significant gastrointestinal tract (GIT) penetration and blood-brain barrier (BBB) permeability, as determined in PAMPA experiments.

YTH-IN-1 is an inhibitor of the five YTH structural domains in the human YTHDF1, YTHDF2, YTHDF3, YTHDC1, and YTHDC2 proteins.The YTH family of proteins is an N 6-methyladenosine (m6A) reader that plays an important regulatory role in gene expression.

D-(+)-Trehalose-13C12 is an isotopic label of D-(+)-Trehalose, enriched with 13C. This compound is pervasively found and often employed as a food ingredient and a shape-forming agent for active molecules.

DSPE-PEG(2000)-TCO is a polyethylene glycol-modified derivative of DSPE for preparing lipid nanoparticles (LNPs), whose TCO moiety undergoes bioorthogonal IEDDA reactions with triazine rings.

DSPE-PEG(2000)-COOH, a 1,2-distearoyl-sn-glycero-3-PE (DSPE) derivative modified by PEGylation and carboxylation, is a non-toxic and biodegradable amphiphilic copolymer that can be used to form micelles to deliver nanoparticles.